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Background
T cells play an important role in the pathogenesis of severe
cutaneous adverse reaction (SCAR), while the role of B cell
immunity in SCAR is unclear. It has been reported that
number of B cell and serum IgG are decreased in the
patient’s peripheral blood of drug-induced hypersensitivity
syndrome (DIHS) / drug reaction with eosinophilia and
systemic symptoms (DRESS) in the acute stage. Regulatory
B cell (Breg) is a IL-10 producing cell and negatively regu-
lates cellular immunity in the mouse autoimmune disease
model. Also in the mouse model, B-1 B cell secretes
immunoglobulin against microbial infection in a T cell-
independent manner. Recently, Breg and B-1 B cell were
identified as minor populations of human B cells in the
peripheral blood, however, the roles of these B cells in
SCAR are unknown. Here, we studied the ratio of Breg
and B-1 B cells in the peripheral blood B cells of SCAR
patients.
Method
Three patients of toxic epidermal necrolysis (TEN), DIHS/
DRESS, and three healthy controls were involved in this
study. Peripheral blood mononuclear cells of SCAR
patients in both acute stage and recovery stage were
stained. CD24hi, CD27+, CD19+ cells and CD27+, CD43
+, CD20+ cells were analyzed as Breg and B-1 B cells,
respectively.
Results
The ratio of B cells in the peripheral blood was decreased
in the acute stage SCAR. Furthermore, the ratio of Breg in
the CD19+ cells was decreased in the acute stage of DIHS.
On the other hand, the ratio of B-1 B cells was different
among patients of TEN and DIHS and there was no clear
tendency.
Conclusion
Although the pathological roles of Breg and B-1 B cell in
SCAR are still unclear, they might contribute to drug-
specific T cell activation or herpes virus reactivation.
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